Pharmacokinetics of intragastric ipriflavone solid dispersion in rats.
To evaluate pharmacokinetic behavior of ipriflavone solid dispersion in rats. The plasma concentrations of ipriflavone in rats were determined by HPLC with UV detector. Plasma concentration-time curves after ig ipriflavone solid dispersion 250 mg.kg-1 in rats were fitted with one-compartment model. Pharmacokinetic parameters were as follows: Ke = 0.21 h-1, T1/2Ke = 5.19 h, Ka = 1.71 h-1, T1/2Ka = 0.41 h, Tmax = 0.67 h, Cmax = 429 micrograms.L-1, AUC = 3916 micrograms.h.L-1; The relative bioavailability of ipriflavone solid dispersion was 323%. Ipriflavone in solid dispersion was absorbed more effectively than that in physical mixture in rats.